Profile: Harvard Apparatus Regenerative Technology Inc (HART.PH)

HART.PH on Philadelphia Stock Exchange

4.10USD
4 Mar 2015
Change (% chg)

-- (--)
Prev Close
$4.10
Open
--
Day's High
--
Day's Low
--
Volume
3
Avg. Vol
75
52-wk High
$11.40
52-wk Low
$2.48

Search Stocks

Harvard Apparatus Regenerative Technology, Inc., incorporated on May 3, 2012, is clinical stage regenerative medicine company developing life-saving medical devices. The Company’s products include Hollow Organ Bioreactors, Solid Organ Bioreactors, Scaffolds, and Clinical Infusion Pump. The Company’s first products are a bioreactor and a synthetic scaffold that can be used by surgeons to create a replacement trachea, or airway, for patients who need an airway transplant. Its bioreactor technology has been used in six human airway transplant surgeries. Its r products are in development. The Company’s products address the critical challenges to trachea transplant, the shortage of suitable donor tracheas. The Company is a wholly owned subsidiary Harvard Bioscience Inc. In October 2013, Harvard Bioscience Inc announced the spin-off of its wholly owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, Inc.

Products

The Company’s InBreath hollow organ bioreactor is a device that can be used by a surgeon to seed cells onto a scaffold. The InBreath bioreactor enables the surgeon to secure the scaffold to the bioreactor; seed the patient’s cells on the scaffold under sterile conditions; automatically rotate the scaffold to allow good cell distribution into the pores of the scaffold, and remotely monitor the scaffold during the course of the two to three days incubation period before the transplant. A scaffold is a natural or synthetic framework, shaped like the real organ, that is porous to allow cells to penetrate the scaffold, attach and start to grow. It has scaffold manufacturing in its Holliston, Massachusetts facility. It has manufactured over 100 prototype scaffolds and intends to provide its scaffolds to surgeons for use in future transplants. The Company also develops a clinical infusion pump that can be used by clinicians as a cell injection system. This product will allow clinicians to inject cells directly into damaged tissue. In addition to the cell injection applications, we expect its clinical pump will be used for infusing drugs in general hospital applications.

Company Address

Harvard Apparatus Regenerative Technology Inc

84 October Hill Rd Ste 11
HOLLISTON   MA   01746-1371
P: +1508.8938999
F: +1302.6745266

Company Web Links

Search Stocks